BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22386698)

  • 1. The influence of renal function on the prognostic value of NT-pro brain natriuretic peptide in ST-elevation myocardial infarction.
    Lazzeri C; Valente S; Chiostri M; Attanà P; Picariello C; Gensini GF
    Int J Cardiol; 2012 May; 156(3):333-5. PubMed ID: 22386698
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction.
    Lorgis L; Cottin Y; Danchin N; Mock L; Sicard P; Buffet P; L'huillier I; Richard C; Beer JC; Touzery C; Gambert P; Zeller M;
    Heart; 2011 Apr; 97(7):551-6. PubMed ID: 21343169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R; Allison MA; Criqui MH
    J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term prognostic role of NT-proBNP in patients after myocardial infarction.
    Coppola G; Corrado E; Augugliaro S; Mulè MC; Rotolo A; Ciaramitaro G; Farinella M; Evola G; Novo G; Evola S; Andolina G; Caruso M; Cospite V; Vitale F; Hoffmann E; Assennato P; Novo S
    Minerva Cardioangiol; 2009 Feb; 57(1):13-21. PubMed ID: 19202516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function.
    Mayr A; Mair J; Schocke M; Klug G; Pedarnig K; Haubner BJ; Nowosielski M; Grubinger T; Pachinger O; Metzler B
    Int J Cardiol; 2011 Feb; 147(1):118-23. PubMed ID: 19896736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
    Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-brain natriuretic peptide and tombstoning ST-segment elevation in patients with anterior wall acute myocardial infarction.
    Tomcsányi J; Marosi A; Bózsik B; Somlói M; Zsoldos A; Vecsey T; Arabadzisz H; Nagy E
    Am J Cardiol; 2005 Nov; 96(9):1197-9. PubMed ID: 16253581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
    J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.
    Sajadieh A; Nielsen OW; Rasmussen V; Ole Hein H; Hansen JF
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1188-94. PubMed ID: 17100670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.